Putnam BioRevolution ETF
SYNB
SYNB was delisted on the 13th of November, 2025.
0 hedge funds and large institutions have $0 invested in Putnam BioRevolution ETF in 2025 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 5 closing their positions.
83.41% less ownership
Funds ownership: 83.41% → 0% (-83%)
100% less funds holding
Funds holding: 5 → 0 (-5)
100% less capital invested
Capital invested by funds: $4.36M → $0 (-$4.36M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 5
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$3.59M |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$389K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$357K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$30.3K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$60 |
SYNB Hedge Fund Activity: Q4 2025 in Review
0 of the 8,225 institutional investors tracked by Wall St. Rank reported a position in Putnam BioRevolution ETF (SYNB) for Q4 2025, worth a combined $0 — down 100% from $4.36M a quarter earlier.
Sellers outnumbered buyers: 5 funds closed out of SYNB and 0 opened new positions — a net loss of 5 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Franklin Resources, exiting entirely with an estimated $3.59M sold.
- 0 institutional investors held Putnam BioRevolution ETF (SYNB) as of Q4 2025, down from 5 in Q3 2025.
- Funds reported $0 of Putnam BioRevolution ETF stock for Q4 2025, down 100% quarter-over-quarter.
- 0 funds opened new Putnam BioRevolution ETF positions in Q4 2025 and 5 closed out, a net change of -5 holders.
- The largest Putnam BioRevolution ETF seller in Q4 2025 was Franklin Resources, an estimated $3.59M sold.
Based on aggregated 13F filings for Q4 2025.